The role of dendritic cells in the immunomodulation to implanted biomaterials

Abstract

Considering the substantial role played by dendritic cells (DCs) in the immune system to bridge innate and adaptive immunity, studies on DC-mediated immunity toward biomaterials principally center on their adjuvant effects in facilitating the adaptive immunity of codelivered antigens. However, the effect of the intrinsic properties of biomaterials on dendritic cells has not been clarified. Recently, researchers have begun to investigate and found that biomaterials that are nonadjuvant could also regulate the immune function of DCs and thus affect subsequent tissue regeneration. In the case of proteins adsorbed onto biomaterial surfaces, their intrinsic properties can direct their orientation and conformation, forming “biomaterial-associated molecular patterns (BAMPs)”. Thus, in this review, we focused on the intrinsic physiochemical properties of biomaterials in the absence of antigens that affect DC immune function and summarized the underlying signaling pathways. Moreover, we preliminarily clarified the specific composition of BAMPs and the interplay between some key molecules and DCs, such as heat shock proteins (HSPs) and high mobility group box 1 (HMGB1). This review provides a new direction for future biomaterial design, through which modulation of host immune responses is applicable to tissue engineering and immunotherapy.

References

[1] Eslami-Kaliji F, Sarafbidabad M, Rajadas J, Mohammadi MR. Dendritic cells as targets for biomaterial-based immunomodulation. ACS Biomater. Sci. Eng., 2020, 6: 2726-2739.

[2] Franz S, Rammelt S, Scharnweber D, Simon JC. Immune responses to implants—A review of the implications for the design of immunomodulatory biomaterials. Biomaterials, 2011, 32: 6692-6709.

[3] Van Brussel I, Berneman ZN, Cools N. Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system. Mediators Inflamm., 2012, 2012: 690643.

[4] Denzer K, . Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J. Immunol., 2000, 165: 1259-1265.

[5] Collin M, McGovern N, Haniffa M. Human dendritic cell subsets. Immunology, 2013, 140: 22-30.

[6] Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology, 2018, 154: 3-20.

[7] Bar-On L, Jung S. Defining dendritic cells by conditional and constitutive cell ablation. Immunol. Rev., 2010, 234: 76-89.

[8] Ohnmacht C, . Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med., 2009, 206: 549-559.

[9] Manicassamy S, Pulendran B. Dendritic cell control of tolerogenic responses. Immunol. Rev., 2011, 241: 206-227.

[10] Constantino J, Gomes C, Falcão A, Neves BM, Cruz MT. Dendritic cell-based immunotherapy: a basic review and recent advances. Immunol. Res., 2017, 65: 798-810.

[11] Worbs T, Hammerschmidt SI, Förster R. Dendritic cell migration in health and disease. Nat. Rev. Immunol., 2017, 17: 30-48.

[12] Morelli AE, Hackstein H, Thomson AW. Potential of tolerogenic dendritic cells for transplantation. Semin. Immunol., 2001, 13: 323-335.

[13] Waisman A, Lukas D, Clausen BE, Yogev N. Dendritic cells as gatekeepers of tolerance. Semin. Immunopathol., 2017, 39: 153-163.

[14] Yin X, Chen S, Eisenbarth SC. Dendritic cell regulation of T helper cells. Annu. Rev. Immunol., 2021, 39: 759-790.

[15] Sadtler K, . Proteomic composition and immunomodulatory properties of urinary bladder matrix scaffolds in homeostasis and injury. Semin. Immunol., 2017, 29: 14-23.

[16] Kou PM, Schwartz Z, Boyan BD, Babensee JE. Dendritic cell responses to surface properties of clinical titanium surfaces. Acta Biomater., 2011, 7: 1354-1363.

[17] Zheng X, Zhou F, Gu Y, Duan X, Mo A. Effect of different titanium surfaces on maturation of murine bone marrow-derived dendritic cells. Sci. Rep., 2017, 7

[18] Yang Y, Wang X, Miron RJ, Zhang X. The interactions of dendritic cells with osteoblasts on titanium surfaces: an in vitro investigation. Clin. Oral. Investig., 2019, 23: 4133-4143.

[19] Moreau A, . Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. FASEB J., 2009, 23: 3070-3077.

[20] Fu H, . Dendritic cells transduced with SOCS1 gene exhibit regulatory DC properties and prolong allograft survival. Cell Mol. Immunol., 2009, 6: 87-95.

[21] Fu CL, Chuang YH, Huang HY, Chiang BL. Induction of IL-10 producing CD4+T cells with regulatory activities by stimulation with IL-10 gene-modified bone marrow derived dendritic cells. Clin. Exp. Immunol., 2008, 153: 258-268.

[22] Levings MK, . Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+Tr cells. Blood, 2005, 105: 1162-1169.

[23] Széles L, . 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J. Immunol., 2009, 182: 2074-2083.

[24] van der Aar AM, . Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells. J. Allergy Clin. Immunol., 2011, 127: 1532-1540.e1537.

[25] Yan X, Zhou M, Yu S, Jin Z, Zhao K. An overview of biodegradable nanomaterials and applications in vaccines. Vaccine, 2020, 38: 1096-1104.

[26] Thomson AW. Tolerogenic dendritic cells: all present and correct. Am. J. Transpl., 2010, 10: 214-219.

[27] Raker VK, Domogalla MP, Steinbrink K. Tolerogenic dendritic cells for regulatory T cell induction in man. Front. Immunol., 2015, 6: 569.

[28] Zhu FJ, Tong YL, Sheng ZY, Yao YM. Role of dendritic cells in the host response to biomaterials and their signaling pathways. Acta Biomater., 2019, 94: 132-144.

[29] Pacelli S, . Tailoring biomaterial surface properties to modulate host-implant interactions: implication in cardiovascular and bone therapy. J. Mater. Chem. B, 2016, 4: 1586-1599.

[30] Abaricia JO, . Control of innate immune response by biomaterial surface topography, energy, and stiffness. Acta Biomater., 2021, 133: 58-73.

[31] Shokouhi B, . The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells. Biomaterials, 2010, 31: 5759-5771.

[32] Leifer CA. Dendritic cells in host response to biologic scaffolds. Semin. Immunol., 2017, 29: 41-48.

[33] Lopresti, S. T. & Brown, B. N. Host response to naturally derived biomaterials-ScienceDirect. In (ed Stephen F. Badylak) Host Response Biomater., 53–79 (Academic Press; 2015).

[34] Anderson, J. M. Biological Responses to Materials. Annu. Rev. Mater. Res. 31, 81–110 (2001).

[35] Doloff JC, . Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primates. Nat. Mater., 2017, 16: 671-680.

[36] Kamath AT, . The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol., 2000, 165: 6762-6770.

[37] Madel MB, . Immune function and diversity of osteoclasts in normal and pathological conditions. Front. Immunol., 2019, 10: 1408.

[38] Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998, 392: 245-252.

[39] Devi KS, Anandasabapathy N. The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues. Semin. Immunopathol., 2017, 39: 137-152.

[40] Schlitzer A, McGovern N, Ginhoux F. Dendritic cells and monocyte-derived cells: Two complementary and integrated functional systems. Semin. Cell Dev. Biol., 2015, 41: 9-22.

[41] Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature, 2007, 449: 419-426.

[42] Rostam HM, Singh S, Vrana NE, Alexander MR, Ghaemmaghami AM. Impact of surface chemistry and topography on the function of antigen presenting cells. Biomater. Sci., 2015, 3: 424-441.

[43] Barone & William, R. Host Response to Biomaterials for Pelvic Floor Reconstruction. (Elsevier Inc., 2015).

[44] Yoshida M, Mata J, Babensee JE. Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells. J. Biomed. Mater. Res. A, 2007, 80: 7-12.

[45] Riol-Blanco L, . The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J. Immunol., 2005, 174: 4070-4080.

[46] Heuzé ML, . Migration of dendritic cells: physical principles, molecular mechanisms, and functional implications. Immunol. Rev., 2013, 256: 240-254.

[47] Hotchkiss KM, Clark NM, Olivares-Navarrete R. Macrophage response to hydrophilic biomaterials regulates MSC recruitment and T-helper cell populations. Biomaterials, 2018, 182: 202-215.

[48] Wculek SK, . Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol., 2020, 20: 7-24.

[49] Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol., 2007, 7: 610-621.

[50] Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu. Rev. Immunol., 2003, 21: 685-711.

[51] Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol., 2007, 7: 585-598.

[52] Steinman RM. The control of immunity and tolerance by dendritic cell. Pathol. Biol., 2003, 51: 59-60.

[53] Gleisner MA, Rosemblatt M, Fierro JA, Bono MR. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype. Transpl. Proc., 2011, 43: 2325-2333.

[54] Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med, 2000, 191: 411-416.

[55] Lewis, J. S. & Keselowsky, B. G. Role of dendritic cells in response to biomaterials. In (ed Stephen F. Badylak) Host Response Biomater., 131–150 (Academic Press; 2015).

[56] Tai Y, Wang Q, Korner H, Zhang L, Wei W. Molecular mechanisms of T cells activation by dendritic cells in autoimmune Diseases. Front Pharm., 2018, 9: 642.

[57] Watanabe N, . Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature, 2005, 436: 1181-1185.

[58] Batool F, . Modulation of immune-inflammatory responses through surface modifications of biomaterials to promote bone healing and regeneration. J. Tissue Eng., 2021, 12: 20417314211041428.

[59] Gammon JM, Jewell CM. Engineering immune tolerance with biomaterials. Adv. Health. Mater., 2019, 8: e1801419.

[60] Wei F, . Host response to biomaterials for cartilage tissue engineering: key to remodeling. Front. Bioeng. Biotechnol., 2021, 9: 664592.

[61] Park J, Babensee JE. Differential functional effects of biomaterials on dendritic cell maturation. Acta Biomater., 2012, 8: 3606-3617.

[62] Babensee JE, Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J. Biomed. Mater. Res A, 2005, 74: 503-510.

[63] Yoshida M, Babensee JE. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J. Biomed. Mater. Res. A, 2006, 79: 393-408.

[64] Acharya AP, Dolgova NV, Clare-Salzler MJ, Keselowsky BG. Adhesive substrate-modulation of adaptive immune responses. Biomaterials, 2008, 29: 4736-4750.

[65] Hof M, . Esthetic evaluation of single-tooth implants in the anterior mandible. Clin. Oral. Implants Res., 2014, 25: 1022-1026.

[66] Acharya AP, Dolgova NV, Xia CQ, Clare-Salzler MJ, Keselowsky BG. Adhesive substrates modulate the activation and stimulatory capacity of non-obese diabetic mouse-derived dendritic cells. Acta Biomater., 2011, 7: 180-192.

[67] Lewis JS, . The effect of cyclic mechanical strain on activation of dendritic cells cultured on adhesive substrates. Biomaterials, 2013, 34: 9063-9070.

[68] Zreiqat H, . The incorporation of strontium and zinc into a calcium-silicon ceramic for bone tissue engineering. Biomaterials, 2010, 31: 3175-3184.

[69] Su Y, . Zinc-based biomaterials for regeneration and therapy. Trends Biotechnol., 2019, 37: 428-441.

[70] Cuozzo RC, . Biological evaluation of zinc-containing calcium alginate-hydroxyapatite composite microspheres for bone regeneration. J. Biomed. Mater. Res B Appl Biomater., 2020, 108: 2610-2620.

[71] Li Y, . Additively manufactured biodegradable porous zinc. Acta Biomater., 2020, 101: 609-623.

[72] George MM, Subramanian Vignesh K, Landero Figueroa JA, Caruso JA, Deepe GS Jr.. Zinc induces dendritic cell tolerogenic Phenotype and Skews Regulatory T Cell-Th17 balance. J. Immunol., 2016, 197: 1864-1876.

[73] Chan G, Mooney DJ. Ca(2+) released from calcium alginate gels can promote inflammatory responses in vitro and in vivo. Acta Biomater., 2013, 9: 9281-9291.

[74] Schuhladen K, . Cu, Zn doped borate bioactive glasses: antibacterial efficacy and dose-dependent in vitro modulation of murine dendritic cells. Biomater. Sci., 2020, 8: 2143-2155.

[75] Li X, . Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy. Sci. Rep., 2017, 7

[76] Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol., 2004, 4: 469-478.

[77] Hotchkiss KM, . Titanium surface characteristics, including topography and wettability, alter macrophage activation. Acta Biomater., 2016, 31: 425-434.

[78] Kopf BS, Ruch S, Berner S, Spencer ND, Maniura-Weber K. The role of nanostructures and hydrophilicity in osseointegration: In-vitro protein-adsorption and blood-interaction studies. J. Biomed. Mater. Res. A, 2015, 103: 2661-2672.

[79] Lu DR, Park K. Effect of surface hydrophobicity on the conformational changes of adsorbed fibrinogen. J. Colloid Interface, 1991, 144: 271-281.

[80] Heuberger M, Drobek T, Spencer ND. Interaction forces and morphology of a protein-resistant poly(ethylene glycol) layer. Biophys. J., 2005, 88: 495-504.

[81] Yang K, Du J, Zhang Z, Liu D, Ren T. Facile and eco-friendly preparation of super-amphiphilic porous polycaprolactone. J. Colloid Interface Sci., 2020, 560: 795-801.

[82] Liu Y, . Surface hydrophobicity of microparticles modulates adjuvanticity. J. Mater. Chem. B, 2013, 1: 3888-3896.

[83] Chaudhary P, Pesacreta TC, Misra RD. Interplay between protein-modified surface and functional response of osteoblasts. J. Biomed. Mater. Res A, 2012, 100: 3157-3166.

[84] Chen R, Ma H, Zhang L, Bryers JD. Precision-porous templated scaffolds of varying pore size drive dendritic cell activation. Biotechnol. Bioeng., 2018, 115: 1086-1095.

[85] Meredith JC, . Combinatorial characterization of cell interactions with polymer surfaces. J. Biomed. Mater. Res A, 2003, 66: 483-490.

[86] Unadkat HV, . An algorithm-based topographical biomaterials library to instruct cell fate. Proc. Natl Acad. Sci. USA, 2011, 108: 16565-16570.

[87] Kou, P. M. Elucidation of dendritic cell response-material property relationships using high-throughput methodologies. Dissertations & Theses–Gradworks (2011).

[88] Daneshmandi S, Dibazar SP, Fateh S. Effects of 3-dimensional culture conditions (collagen-chitosan nano-scaffolds) on maturation of dendritic cells and their capacity to interact with T-lymphocytes. J. Immunotoxicol., 2016, 13: 235-242.

[89] Groell F, Kalia YN, Jordan O, Borchard G. Hydrogels in three-dimensional dendritic cell (MUTZ-3) culture as a scaffold to mimic human immuno competent subcutaneous tissue. Int J. Pharm., 2018, 544: 297-303.

[90] van den Dries K, . Geometry sensing by dendritic cells dictates spatial organization and PGE(2)-induced dissolution of podosomes. Cell Mol. Life Sci., 2012, 69: 1889-1901.

[91] Sapudom J, . Dendritic cell immune potency on 2D and in 3D collagen matrices. Biomater. Sci., 2020, 8: 5106-5120.

[92] Rupp F, . Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. J. Biomed. Mater. Res A, 2006, 76: 323-334.

[93] Buser D, . Enhanced bone apposition to a chemically modified SLA titanium surface. J. Dent. Res., 2004, 83: 529-533.

[94] Zhao G, . High surface energy enhances cell response to titanium substrate microstructure. J. Biomed. Mater. Res. A, 2005, 74: 49-58.

[95] Schwarz F, . Potential of chemically modified hydrophilic surface characteristics to support tissue integration of titanium dental implants. J. Biomed. Mater. Res B Appl Biomater., 2009, 88: 544-557.

[96] Alfarsi MA, Hamlet SM, Ivanovski S. Titanium surface hydrophilicity enhances platelet activation. Dent. Mater. J., 2014, 33: 749-756.

[97] Park J, Gerber MH, Babensee JE. Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells. J. Biomed. Mater. Res A, 2015, 103: 170-184.

[98] Andorko JI, Pineault KG, Jewell CM. Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino) esters. J. Biomed. Mater. Res. A, 2017, 105: 1219-1229.

[99] Ma Y, . The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses. Nanoscale, 2011, 3: 2307-2314.

[100] Terhune J, Berk E, Czerniecki BJ. Dendritic cell-induced Th1 and Th17 cell differentiation for cancer therapy. Vaccines, 2013, 1: 527-549.

[101] Tomić S, . Graphene quantum dots suppress proinflammatory T cell responses via autophagy-dependent induction of tolerogenic dendritic cells. Biomaterials, 2017, 146: 13-28.

[102] Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small, 2010, 6: 12-21.

[103] Silva AL, . Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation. Semin. Immunol., 2017, 34: 3-24.

[104] Vitor MT, . Cationic liposomes produced via ethanol injection method for dendritic cell therapy. J. Liposome Res, 2017, 27: 249-263.

[105] Cong X, . Cationic Liposome/DNA complexes mediate antitumor immunotherapy by promoting immunogenic tumor cell death and dendritic cell activation. ACS Appl Mater. Interfaces, 2020, 12: 28047-28056.

[106] Ni Q, . A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer. Sci. Adv., 2020, 6: eaaw6071.

[107] Tangpasuthadol V, Pongchaisirikul N, Hoven VP. Surface modification of chitosan films. Eff. Hydrophobicity Protein Adsorpt. Carbohydr. Res, 2003, 338: 937-942.

[108] Hong H, . Digital light processing 3D printed silk fibroin hydrogel for cartilage tissue engineering. Biomaterials, 2020, 232: 119679.

[109] Ebhodaghe SO. Natural polymeric scaffolds for tissue engineering applications. J. Biomater. Sci. Polym. Ed., 2021, 32: 2144-2194.

[110] Lewis JS, . Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres. J. Mater. Chem. B, 2014, 2: 2562-2574.

[111] Firkowska-Boden, I., Zhang, X. & Jandt, K. D. Controlling protein adsorption through nanostructured polymeric surfaces. Adv. Healthc. Mater. 7, https://doi.org/10.1002/adhm.201700995 (2018).

[112] Boddupalli A, Zhu L, Bratlie KM. Methods for implant acceptance and wound healing: material selection and implant location modulate macrophage and fibroblast phenotypes. Adv. Health. Mater., 2016, 5: 2575-2594.

[113] Horbett TA. Fibrinogen adsorption to biomaterials. J. Biomed. Mater. Res. A, 2018, 106: 2777-2788.

[114] Abdallah MN, . Biomaterial surface proteomic signature determines interaction with epithelial cells. Acta Biomater., 2017, 54: 150-163.

[115] Babensee JE. Interaction of dendritic cells with biomaterials. Semin Immunol., 2008, 20: 101-108.

[116] Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med, 2003, 197: 1107-1117.

[117] Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol., 2006, 6: 33-43.

[118] Brand U, . Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur. J. Immunol., 1998, 28: 1673-1680.

[119] Tsai AT, . The role of osteopontin in foreign body giant cell formation. Biomaterials, 2005, 26: 5835-5843.

[120] McNally AK, Jones JA, Macewan SR, Colton E, Anderson JM. Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. J. Biomed. Mater. Res A, 2008, 86: 535-543.

[121] Keselowsky BG, . Role of plasma fibronectin in the foreign body response to biomaterials. Biomaterials, 2007, 28: 3626-3631.

[122] Escalante T, . Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins. J. Proteome Res., 2009, 8: 5120-5131.

[123] Swartzlander MD, . Linking the foreign body response and protein adsorption to PEG-based hydrogels using proteomics. Biomaterials, 2015, 41: 26-36.

[124] Ruoslahti E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol., 1996, 12: 697-715.

[125] Ryu JJ, Park K, Kim HS, Jeong CM, Huh JB. Effects of anodized titanium with Arg-Gly-Asp (RGD) peptide immobilized via chemical grafting or physical adsorption on bone cell adhesion and differentiation. Int J. Oral. Maxillofac. Implants, 2013, 28: 963-972.

[126] Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature, 1984, 309: 30-33.

[127] Hotaling, N. A. Elucidation and optimization of molecular factors for dendritic cell responses to surface presented glycans. Georgia Institute of Technology (2013).

[128] Aukhil I. Biology of wound healing. Periodontol 2000, 2000, 22: 44-50.

[129] Love RJ, Jones KS. The recognition of biomaterials: pattern recognition of medical polymers and their adsorbed biomolecules. J. Biomed. Mater. Res A, 2013, 101: 2740-2752.

[130] Rowley AT, Nagalla RR, Wang SW, Liu WF. Extracellular matrix-based strategies for immunomodulatory biomaterials engineering. Adv. Health. Mater., 2019, 8: e1801578.

[131] Jang, Y. H. et al. Molecular-level interactions between engineered materials and cells. Int. J. Mol. Sci. 20, https://doi.org/10.3390/ijms20174142 (2019).

[132] Acharya AP, . The modulation of dendritic cell integrin binding and activation by RGD-peptide density gradient substrates. Biomaterials, 2010, 31: 7444-7454.

[133] McKiel LA, Fitzpatrick LE. Toll-like receptor 2-dependent NF-κB/AP-1 activation by damage-associated molecular patterns adsorbed on polymeric surfaces. ACS Biomater. Sci. Eng., 2018, 4: 3792-3801.

[134] Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol., 2007, 81: 1-5.

[135] Tancharoen, S. et al. HMGB1 promotes intraoral palatal wound healing through RAGE-dependent mechanisms. Int. J. Mol. Sci. 17, https://doi.org/10.3390/ijms17111961 (2016).

[136] Ranathunga DTS, Arteaga A, Biguetti CC, Rodrigues DC, Nielsen SO. Molecular-level understanding of the influence of ions and water on HMGB1 adsorption induced by surface hydroxylation of titanium implants. Langmuir, 2021, 37: 10100-10114.

[137] Biguetti CC, . HGMB1 and RAGE as essential components of Ti Osseointegration process in mice. Front Immunol., 2019, 10: 709.

[138] Bennewitz NL, Babensee JE. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials, 2005, 26: 2991-2999.

[139] Bethke K, . Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60. J. Immunol., 2002, 169: 6141-6148.

[140] Kato S, Akagi T, Sugimura K, Kishida A, Akashi M. Evaluation of biological responses to polymeric biomaterials by RT-PCR analysis III: study of HSP 70, 90 and 47 mRNA expression. Biomaterials, 1998, 19: 821-827.

[141] Zhou J, An H, Xu H, Liu S, Cao X. Heat shock up-regulates expression of Toll-like receptor-2 and Toll-like receptor-4 in human monocytes via p38 kinase signal pathway. Immunology, 2005, 114: 522-530.

[142] Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng., 2005, 11: 1-18.

[143] Hirata T, . Effect of local chain dynamics on a bioinert interface. Langmuir, 2015, 31: 3661-3667.

[144] Wu J, Lin W, Wang Z, Chen S, Chang Y. Investigation of the hydration of nonfouling material poly(sulfobetaine methacrylate) by low-field nuclear magnetic resonance. Langmuir, 2012, 28: 7436-7441.

[145] Hašek, J. Poly (ethylene glycol) interactions with proteins. Z. Kristallogr. Suppl 23, 613–618 (2006).

[146] Kang B, Opatz T, Landfester K, Wurm FR. Carbohydrate nanocarriers in biomedical applications: functionalization and construction. Chem. Soc. Rev., 2015, 44: 8301-8325.

[147] Patwa TH, Zhao J, Anderson MA, Simeone DM, Lubman DM. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Anal. Chem., 2006, 78: 6411-6421.

[148] Keselowsky BG, Collard DM, García AJ. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J. Biomed. Mater. Res A, 2003, 66: 247-259.

[149] Shankar SP, Chen II, Keselowsky BG, García AJ, Babensee JE. Profiles of carbohydrate ligands associated with adsorbed proteins on self-assembled monolayers of defined chemistries. J. Biomed. Mater. Res A, 2010, 92: 1329-1342.

[150] Shankar SP, Petrie TA, García AJ, Babensee JE. Dendritic cell responses to self-assembled monolayers of defined chemistries. J. Biomed. Mater. Res A, 2010, 92: 1487-1499.

[151] Chalabi S, . Differential O-glycosylation of a conserved domain expressed in murine and human ZP3. Biochemistry, 2006, 45: 637-647.

[152] Cornelius RM, Shankar SP, Brash JL, Babensee JE. Immunoblot analysis of proteins associated with self-assembled monolayer surfaces of defined chemistries. J. Biomed. Mater. Res. A, 2011, 98: 7-18.

[153] Kou PM, Babensee JE. Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype. Acta Biomater., 2010, 6: 2621-2630.

[154] Kou PM, . Predicting biomaterial property-dendritic cell phenotype relationships from the multivariate analysis of responses to polymethacrylates. Biomaterials, 2012, 33: 1699-1713.

[155] Yang J, . Polymer surface functionalities that control human embryoid body cell adhesion revealed by high throughput surface characterization of combinatorial material microarrays. Biomaterials, 2010, 31: 8827-8838.

[156] Garcia-Cordero JL, Nembrini C, Stano A, Hubbell JA, Maerkl SJ. A high-throughput nanoimmunoassay chip applied to large-scale vaccine adjuvant screening. Integr. Biol., 2013, 5: 650-658.

[157] Sinha N, Subedi N, Tel J. Integrating immunology and microfluidics for single immune cell analysis. Front Immunol., 2018, 9: 2373.

[158] Hotaling NA, Tang L, Irvine DJ, Babensee JE. Biomaterial strategies for immunomodulation. Annu. Rev. Biomed. Eng., 2015, 17: 317-349.

[159] Kapp TG, Rechenmacher F, Sobahi TR, Kessler H. Integrin modulators: a patent review. Expert Opin. Ther. Pat., 2013, 23: 1273-1295.

[160] Winograd-Katz SE, Fässler R, Geiger B, Legate KR. The integrin adhesome: from genes and proteins to human disease. Nat. Rev. Mol. Cell Biol., 2014, 15: 273-288.

[161] Schittenhelm L, Hilkens CM, Morrison VL. β(2) Integrins as regulators of dendritic cell, monocyte, and macrophage function. Front. Immunol., 2017, 8: 1866.

[162] Benvenuti F. The dendritic cell synapse: a life dedicated to T cell activation. Front. Immunol., 2016, 7: 70.

[163] Ling GS, . Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophages. Nat. Commun., 2014, 5

[164] Rogers TH, Babensee JE. The role of integrins in the recognition and response of dendritic cells to biomaterials. Biomaterials, 2011, 32: 1270-1279.

[165] Franz S, Rammelt S, Scharnweber D, Simon JC. Immune responses to implants—a review of the implications for the design of immunomodulatory. Biomater. Biomater., 2011, 32: 6692-6709.

[166] de Fougerolles AR, . Global expression analysis of extracellular matrix-integrin interactions in monocytes. Immunity, 2000, 13: 749-758.

[167] van Vliet SJ, den Dunnen J, Gringhuis SI, Geijtenbeek TB, van Kooyk Y. Innate signaling and regulation of Dendritic cell immunity. Curr. Opin. Immunol., 2007, 19: 435-440.

[168] Yoshida M, Babensee JE. Molecular aspects of microparticle phagocytosis by dendritic cells. J. Biomater. Sci. Polym. Ed., 2006, 17: 893-907.

[169] Gay NJ, Symmons MF, Gangloff M, Bryant CE. Assembly and localization of Toll-like receptor signalling complexes. Nat. Rev. Immunol., 2014, 14: 546-558.

[170] Satoh, T. & Akira, S. Toll-like receptor signaling and its inducible proteins. Microbiol. Spectr. 4, (2016) https://doi.org/10.1128/microbiolspec.MCHD-0040-2016

[171] Rogers TH, Babensee JE. Altered adherent leukocyte profile on biomaterials in Toll-like receptor 4 deficient mice. Biomaterials, 2010, 31: 594-601.

[172] Fore F, Indriputri C, Mamutse J, Nugraha J. TLR10 and its unique anti-inflammatory properties and potential use as a target in therapeutics. Immune Netw., 2020, 20: e21.

[173] Balenga NA, Balenga NA. Human TLR11 gene is repressed due to its probable interaction with profilin expressed in human. Med. Hypotheses, 2007, 68: 456.

[174] Celhar T, Magalhães R, Fairhurst AM. TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol. Res., 2012, 53: 58-77.

[175] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol., 2010, 11: 373-384.

[176] Lin SC, Lo YC, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature, 2010, 465: 885-890.

[177] Pearl JI, . Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials, 2011, 32: 5535-5542.

[178] Ajibade AA, Wang HY, Wang RF. Cell type-specific function of TAK1 in innate immune signaling. Trends Immunol., 2013, 34: 307-316.

[179] Chen ZJ. Ubiquitination in signaling to and activation of IKK. Immunol. Rev., 2012, 246: 95-106.

[180] May MJ, Ghosh S. Signal transduction through NF-kappa B. Immunol. Today, 1998, 19: 80-88.

[181] Mitchell S, Vargas J, Hoffmann A. Signaling via the NFκB system. Wiley Interdiscip. Rev. Syst. Biol. Med., 2016, 8: 227-241.

[182] O’Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol., 2007, 7: 353-364.

[183] Flo TH, . Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J. Biol. Chem., 2002, 277: 35489-35495.

[184] Maitra R, Clement CC, Crisi GM, Cobelli N, Santambrogio L. Immunogenecity of modified alkane polymers is mediated through TLR1/2 activation. PLoS One, 2008, 3: e2438.

[185] Chen H, . The promotion of type 1T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion. Biomaterials, 2010, 31: 8172-8180.

[186] Amer LD, . Inflammation via myeloid differentiation primary response gene 88 signaling mediates the fibrotic response to implantable synthetic poly(ethylene glycol) hydrogels. Acta Biomater., 2019, 100: 105-117.

[187] Wang L, . Manipulation of macrophage polarization by peptide-coated gold nanoparticles and its protective effects on acute lung injury. J. Nanobiotechnology, 2020, 18

[188] Padovan E, Landmann RM, De Libero G. How pattern recognition receptor triggering influences T cell responses: a new look into the system. Trends Immunol., 2007, 28: 308-314.

[189] Mazgaeen, L. & Gurung, P. Recent advances in lipopolysaccharide recognition systems. Int. J. Mol. Sci. 21, (2020) https://doi.org/10.3390/ijms21020379

[190] Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol., 2011, 29: 139-162.

[191] Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol. Rev., 2011, 91: 221-264.

[192] Oliveira MI, . Adsorbed Fibrinogen stimulates TLR-4 on monocytes and induces BMP-2 expression. Acta Biomater., 2017, 49: 296-305.

[193] Auquit-Auckbur I, . Role of toll-like receptor 4 in the inflammation reaction surrounding silicone prosthesis. Acta Biomater., 2011, 7: 2047-2052.

[194] Uto T, . The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway. Biomaterials, 2011, 32: 5206-5212.

[195] Bojarová P, Křen V. Sugared biomaterial binding lectins: achievements and perspectives. Biomater. Sci., 2016, 4: 1142-1160.

[196] Lepenies B, Lee J, Sonkaria S. Targeting C-type lectin receptors with multivalent carbohydrate ligands. Adv. Drug Deliv. Rev., 2013, 65: 1271-1281.

[197] van Kooyk Y, Rabinovich GA. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol., 2008, 9: 593-601.

[198] van Kooyk Y. C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem. Soc. Trans., 2008, 36: 1478-1481.

[199] García-Vallejo JJ, . Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol. Immunol., 2013, 53: 387-397.

[200] Bonifaz L, . Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+T cell tolerance. J. Exp. Med., 2002, 196: 1627-1638.

[201] Chen Y, De Koker S, De Geest BG. Engineering strategies for lymph node targeted immune activation. Acc. Chem. Res., 2020, 53: 2055-2067.

[202] Hotaling NA, Cummings RD, Ratner DM, Babensee JE. Molecular factors in dendritic cell responses to adsorbed glycoconjugates. Biomaterials, 2014, 35: 5862-5874.

[203] Hotaling NA, Ratner DM, Cummings RD, Babensee JE. Presentation modality of Glycoconjugates modulates dendritic cell phenotype. Biomater. Sci., 2014, 2: 1426-1439.

[204] Geijtenbeek TB, van Vliet SJ, Engering AT, Hart BA, van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol., 2004, 22: 33-54.

[205] Dambuza IM, Brown GD. C-type lectins in immunity: recent developments. Curr. Opin. Immunol., 2015, 32: 21-27.

[206] Hatscher, L., Amon, L., Heger, L. & Dudziak, D. Inflammasomes in dendritic cells: Friend or foe? Immunol. Lett. 234, 16–32 (2021).

[207] Lamkanfi M, Dixit VM. Modulation of inflammasome pathways by bacterial and viral pathogens. J. Immunol., 2011, 187: 597-602.

[208] He, Y., Hara, H. & Núñez, G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem. Sci. 41, 1012–1021 (2016).

[209] Seydoux, E. et al. Effective combination adjuvants engage both TLR and inflammasome pathways to promote potent adaptive immune responses. J. Immunol., https://doi.org/10.4049/jimmunol.1701604

[210] Ghiringhelli F, . Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med., 2009, 15: 1170-1178.

[211] Zhivaki, D. et al. Inflammasomes within hyperactive murine dendritic cells stimulate long-lived T cell-mediated anti-tumor immunity. Cell Rep. 33, 108381 (2020).

[212] Shaw PJ, Mcdermott MF, Kanneganti TD. Inflammasomes and autoimmunity. Trends Mol. Med., 2011, 17: 57-64.

[213] Li WA, Lu BY, Luo G, Choi Y, Mooney DJ. The effect of surface modification of mesoporous silica micro-rod scaffold on immune cell activation and infiltration. Biomaterials, 2016, 83: 249-256.

[214] Sharp FA, . Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl Acad. Sci. USA, 2009, 106: 870-875.

[215] Si, Y. et al. MyD88 in antigen-presenting cells is not required for CD4+ T-cell responses during peptide nanofiber vaccination. Med. Chem. Commun. 9, 138–148 (2018).

[216] Hornung V, . Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol., 2008, 9: 847-856.

[217] Saikat, M. et al. Immunomodulation of the NLRP3 inflammasome through structure-based activator design and functional regulation via lysosomal rupture. ACS Cent. Sci., (2018) https://doi.org/10.1021/acscentsci.8b0021.

[218] Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr. Biol., 2014, 24: R453-R462.

[219] Malinarich F, . High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells. J. Immunol., 2015, 194: 5174-5186.

[220] Kim J, Kundu M, Viollet B, Guan K-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol., 2011, 13: 132-141.

[221] Hulea L, Markovic Z, Topisirovic I, Simmet T, Trajkovic V. Biomedical potential of mTOR modulation by nanoparticles. Trends Biotechnol., 2016, 34: 349-353.

[222] Sukhbaatar N, Hengstschläger M, Weichhart T. mTOR-mediated regulation of dendritic cell differentiation and function. Trends Immunol., 2016, 37: 778-789.

[223] Feng Y, Yao Z, Klionsky DJ. How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol., 2015, 25: 354-363.

[224] Volarevic V, . Large graphene quantum dots alleviate immune-mediated liver damage. ACS Nano, 2014, 8: 12098-12109.

[225] Qin Y, . Graphene quantum dots induce apoptosis, autophagy, and inflammatory response via p38 mitogen-activated protein kinase and nuclear factor-κB mediated signaling pathways in activated THP-1 macrophages. Toxicology, 2015, 327: 62-76.

[226] Chang CP, Su YC, Hu CW, Lei HY. TLR2-dependent selective autophagy regulates NF-κB lysosomal degradation in hepatoma-derived M2 macrophage differentiation. Cell Death Differ., 2013, 20: 515-523.

[227] Said, A. Bock, S. Lajqi, T. Müller, G. Weindl, G. Chloroquine promotes IL-17 production by CD4+T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells. J. Immunol. 193, 6135–6145 (2014) https://doi.org/10.4049/jimmunol.1303276.

Funding

Key Research and Development Program of Science and Technology Department of Zhejiang Province (no. 2019C03081).